What is Infusion Therapy - Tysabri?
Infusion therapy with Tysabri is a medical procedure used to treat certain autoimmune diseases, particularly multiple sclerosis (MS) and Crohn's disease. It involves the administration of a medication called Tysabri through an intravenous (IV) drip.
Tysabri is a medication that helps suppress the abnormal immune response seen in these conditions. It works by targeting specific cells and molecules in the body that play a role in causing inflammation and damage to the nervous system or intestines.
This therapy is typically recommended for individuals who have moderate to severe symptoms or have not responded well to other treatments. People who experience frequent relapses in their MS or have severe symptoms in Crohn's disease may benefit from Tysabri infusion therapy.
During the procedure, a nurse or healthcare professional will insert a small plastic tube, called an IV catheter, into a vein, usually in the arm. This allows the medication to be delivered directly into the bloodstream. The Tysabri solution is then slowly infused into the body over the course of about one hour.
The frequency of Tysabri infusions varies depending on the individual's condition, but it is typically given once every 4 weeks. Each infusion session can take around 2-3 hours in total, including preparation time, monitoring, and post-infusion observation.
The benefits of Tysabri infusion therapy can be significant for individuals with MS or Crohn's disease. It can help reduce the frequency of relapses in MS and improve overall disease control. In Crohn's disease, it can help reduce symptoms such as abdominal pain, diarrhea, and inflammation. By suppressing the immune system, Tysabri aims to lessen the severity of symptoms and slow down the progression of these conditions.
However, like any medical procedure, there are risks and potential complications associated with Tysabri infusion therapy. One significant risk is the possibility of developing a rare but serious brain infection called progressive multifocal leukoencephalopathy (PML). This risk is higher for individuals who have been exposed to the JC virus, which is commonly present in the general population. Regular monitoring and testing may help identify the risk of developing PML. Other potential side effects may include allergic reactions, fatigue, infusion-related reactions, and increased risk of infections.
After the infusion, patients will usually be observed for a period of time to ensure there are no immediate adverse reactions to the medication. Some individuals may experience mild side effects, such as headache or nausea, but these typically resolve on their own. Recovery from the procedure is generally quick, and patients can resume their normal activities shortly after the infusion.
It's important to note that Tysabri infusion therapy requires close monitoring and periodic evaluations by a healthcare professional to ensure its effectiveness and safety. Regularly discussing any concerns or potential side effects with the healthcare team is essential to maintain optimal care and management of the underlying autoimmune condition.
Symptoms for Infusion Therapy - Tysabri
Tysabri is a medication used in infusion therapy to treat certain autoimmune disorders, primarily multiple sclerosis (MS) and Crohn's disease. Here are some common symptoms associated with the infusion therapy procedure using Tysabri:
1. Fatigue: Some patients may experience tiredness or fatigue after the infusion, which can last for a few hours or a few days.
2. Headache: Headaches are a common side effect and can be mild to moderate in intensity. They usually resolve on their own without treatment.
3. Nausea: Some individuals may feel nauseous during or shortly after the infusion. This symptom is generally mild and transient.
4. Allergic reactions: While rare, allergic reactions to Tysabri may occur during or immediately after the infusion. Symptoms may include skin rash, itching, swelling, difficulty breathing, and dizziness. If this occurs, immediate medical attention is necessary.
5. Infection: Tysabri can increase the risk of certain infections, including progressive multifocal leukoencephalopathy (PML). Symptoms of PML may include changes in vision, difficulty speaking or understanding, weakness on one side of the body, and problems with coordination.
6. Infusion site reactions: Some patients may experience minor reactions at the site of infusion, such as redness, swelling, or pain. These reactions are usually minimal and resolve within a few days.
7. Depression or mood changes: In rare cases, Tysabri has been associated with an increased risk of depression or other mood changes. Patients should report any new or worsening mood symptoms to their healthcare provider.
It's important to note that the symptoms mentioned above can vary from person to person. Patients starting Tysabri infusion therapy should be closely monitored by healthcare professionals to ensure they receive the appropriate care and support.
How can a Cash Pay Health Care Marketplace help with IV Therapy like these in Westphalia, Michigan?
IV Therapy like Infusion Therapy - Tysabri can be very costly procedures. Our members can save up to 90% on outpatient elective procedures.